Tag: Clinical-Stage
Companies Pioneering Novel Solutions to Tackle Obesity
Obesity and overweight together are the leading cause of preventable death in the U.S leading to a loss of 47 percent more life years...
CHALLENGING INSOMNIA BY INNOVATIVE RE-ENGINEERING OF THE NEURAL PATHWAYS
The Global Market for Insomnia is estimated to reach $5,488 million by 2023 from $4,093 million in 2016 at a CAGR of 4.2% according to a report...
We are looking for talented interns to learn and help investors find valuable companies.